Chiusura precedente | 10,85 |
Aperto | 10,60 |
Denaro | 0,00 x 0 |
Lettera | 0,00 x 0 |
Min-Max giorno | 9,98 - 10,72 |
Intervallo di 52 settimane | 9,98 - 10,72 |
Volume | |
Media Volume | N/D |
Capitalizzazione | 898,789M |
Beta (5 anni mensile) | 0,98 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -0,71 |
Prossima data utili | N/D |
Rendimento e dividendo (forward) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
VALNEVA Declaration of shares and voting rights Interim status at June 22, 2022__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment A Declaration date: June 27, 2022 Number of shares composing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the change Date on wh
Saint-Herblain (France), June 24, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Management Board were approved by the shareholders at its Annual General Meeting (AGM) held yesterday in Paris. Among the adopted resolutions were approval of the 2021 financial statements, delegations for the management board to increase Valneva’s share capital and/or issue financial instruments, and the appointment, fo
Saint-Herblain (France) and New York, June 23, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced the closing of the equity investment announced on June 20, 2022.1 Pursuant to an Equity Subscription Agreement, Pfizer has invested €90.5 ($95) million in Valneva, representing 8.1% of Valneva’s share capital at a price of €9.49 per share, through a reserved capital increase. Valneva is planning to use the proceeds to suppo